DacarbazineMelanomaSkin NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsMelanoma, ExperimentalNeoplasm MetastasisVinblastineAntineoplastic Agents, AlkylatingBleomycinAntineoplastic AgentsChemotherapy, AdjuvantTreatment OutcomeDoxorubicinCombined Modality TherapyMART-1 AntigenCisplatinHodgkin Diseasegp100 Melanoma AntigenDisease-Free SurvivalNevusMechlorethamineSurvival AnalysisNevus, PigmentedProto-Oncogene Proteins B-rafNeoplasm StagingCell Line, TumorCyclophosphamideProcarbazineInterferon-alphaDrug Administration ScheduleSurvival RateMelanoma, AmelanoticCarmustineInterleukin-2Antigens, NeoplasmUveal NeoplasmsLomustinePrognosisMelanoma-Specific AntigensLymphocytes, Tumor-InfiltratingLung NeoplasmsDisease ProgressionCancer VaccinesMelanocytesImmunotherapyNeoplasm ProteinsEtoposideChoroid NeoplasmsAntibodies, MonoclonalDysplastic Nevus SyndromeMonophenol MonooxygenaseNimustineNitrosourea CompoundsVincristineDrug Resistance, NeoplasmTumor Cells, CulturedKaplan-Meier EstimateLymphatic MetastasisMesnaGene Expression Regulation, NeoplasticTumor Markers, BiologicalImmunotherapy, AdoptiveIfosfamideBenzenesulfonatesTamoxifenNeoplasmsRecombinant ProteinsChillsNeoadjuvant TherapyImmunohistochemistryTime FactorsMice, NudeDose-Response Relationship, DrugBreast NeoplasmsNeoplasm Recurrence, LocalInfusions, IntravenousO(6)-Methylguanine-DNA MethyltransferaseBrain NeoplasmsFollow-Up StudiesNeoplasm InvasivenessApoptosisSarcomaPaclitaxelMelaninsNiacinamideEye NeoplasmsCarboplatinMicrophthalmia-Associated Transcription FactorPhenylurea CompoundsPrednisoneCTLA-4 AntigenRadiotherapy, AdjuvantVindesineNauseaThrombocytopeniaNeoplasm TransplantationHLA-A2 AntigenProspective StudiesSalvage TherapyMethotrexate